Early steroid withdrawal in repeat kidney transplantation

Clinical Journal of the American Society of Nephrology

Volumn 6, Issue 2, 2011, Pages 404-411

  Mujtaba, Muhammad A ^a   Taber, Tim E ^a   Goggins, William C ^a   Yaqub, Muhammad S ^a   Mishler, Dennis P ^a   Milgrom, Martin L ^a   Fridell, Jonathan A ^a   Lobashevsky, Andrew ^a   Powelson, John A ^a   Sharfuddin, Asif A ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RITUXIMAB; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; DIABETES MELLITUS; DRUG DOSE REDUCTION; DRUG PULSE THERAPY; EARLY TREATMENT WITHDRAWAL; FEMALE; GRAFT SURVIVAL; HUMAN; HYPERLIPIDEMIA; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; OUTCOME ASSESSMENT; PLASMAPHERESIS; RETROSPECTIVE STUDY; STEROID THERAPY; SURVIVAL; TREATMENT WITHDRAWAL;

ADULT; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INDIANA; KAPLAN-MEIER ESTIMATE; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; REOPERATION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STEROIDS; TIME FACTORS; TREATMENT OUTCOME;

EID: 79951916396     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.05110610     Document Type: Article

References (40)

1. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, Chapman JR, Nankivell BJ, Borrows RJ, Fung CLS, O'Connell PJ, Allen RDM, Chapman JR: The natural history of chronic allograft nephropathy. N Engl J Med 349: 2326-2333, 2003 (Pubitemid 37509740)
2. El-Zoghby ZM, Stegall MD, Lager DJ, Kremers WK, Am H, Gloor JM, Cosio FG: Identifying specific causes of kidney allograft loss. Am J Transplant 9: 527-535, 2009
3. Cecka JM, Cecka JM: The UNOS Renal Transplant Registry. Clin Transplants 16: 1-20, 2002
4. 2010 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 2004-2009, Rockville, MD, U.S. Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation
5. Ahmed K, Ahmad N, Khan MS, Koffman G, Calder F, Taylor J, Mamode N: Influence of number of retransplants on renal graft outcome. Transplant Proc 40: 1349-1352, 2008 (Pubitemid 351853193)
6. Barocci S, Valente U, Fontana I, Tagliamacco A, Santori G, Mossa M, Ferrari E, Trovatello G, Centore C, Lorenzi S, Rolla D, Nocera A: Long-term outcome on kidney retransplantation: A review of 100 cases from a single center. Transplant Proc 41: 1156-1158, 2009
7. El-Agroudy AE, Wafa EW, Bakr MA, Donia AF, Ismail AM, Shokeir AA, El-Dein ABS, Ghoneim M: Living-donor kidney retransplantation: Risk factors and outcome. BJU Int 94: 369-373, 2004 (Pubitemid 39120181)
8. Hirata M, Terasaki PI: Renal retransplantation. Clin Transplants 8: 419-433, 1994
9. Ojo A, Wolfe RA, Agodoa LY, Held PJ, Port FK, Leavey SF, Callard SE, Dickinson DM, Schmouder RL, Leichtman AB: Prognosis after primary renal transplant failure and the beneficial effects of repeat transplantation: multivariate analyses from the United States Renal Data System. Transplantation 66: 1651-1659, 1998 (Pubitemid 29034986)
10. Rao PS, Schaubel DE, Wei G, Fenton SSA: Evaluating the survival benefit of kidney retransplantation. Transplantation 82: 669-674, 2006 (Pubitemid 44395238)
11. Scornik JC: Detection of alloantibodies by flow cytometry: Relevance to clinical transplantation. Cytometry 22: 259-263, 1995
12. Hricik DE: Steroid-free immunosuppression in kidney transplantation: An editorial review. Am J Transplant 2: 19-24, 2002
13. Matas AJ, Kandaswamy R, Gillingham KJ, McHugh L, Ibrahim H, Kasiske B, Humar A: Prednisone-free maintenance immunosuppression: A 5-year experience. Am J Transplant 5: 2473-2478, 2005
14. Veenstra DL, Best JH, Hornberger J, Sullivan SD, Hricik DE: Incidence and long-term cost of steroid-related side effects after renal transplantation. Am J Kidney Dis 33: 829-839,1999 (Pubitemid 29214678)
15. Vincenti F, Schena FP, Paraskevas S, Hauser IA, Walker RG, Grinyo J, Group FS: A randomized, multicenter study of steroid avoidance, early steroid withdrawal or standard steroid therapy in kidney transplant recipients. Am J Transplantat 8: 307-316, 2008
16. Miller LW: Cardiovascular toxicities of immunosuppressive agents. Am J Transplant 2: 807-818, 2002
17. Prasad GVR, Nash MM, McFarlane PA, Zaltzman JS: Renal transplant recipient attitudes toward steroid use and steroid withdrawal. Clin Transplant 17: 135-139, 2003 (Pubitemid 36833785)
18. Hricik D, O'Toole M, Schulak J, Herson J: Steroid-free immunosuppression in cyclosporine-treated renal transplant recipients: A meta-analysis. J Am Soc Nephrol 4: 1300-1305, 1993
19. Kaufman DB, Leventhal JR, Axelrod D, Gallon LG, Parker MA, Stuart FP, Kaufman DB, Leventhal JR, Axelrod D, Gallon LG, Parker MA, Stuart FP: Alemtuzumab induction and prednisone-free maintenance immunotherapy in kidney transplantation: Comparison with basiliximab induction - long-term results. Am J Transplant 5: 2539-2548, 2005
20. Tan HP, Donaldson J, Basu A, Unruh M, Randhawa P, Sharma V, Morgan C, McCauley J, Wu C, Shah N, Zeevi A, Shapiro R: Two hundred living donor kidney transplantations under alemtuzumab induction and tacrolimus monotherapy: 3-year follow-up. Am J Transplant 9: 355-366, 2009
21. Tan HP, Kaczorowski D, Basu A, McCauley J, Marcos A, Donaldson J, Unruh M, Randhawa P, Zeevi A, Shapiro R: Steroid-free tacrolimus monotherapy after pretransplantation thymoglobulin or campath and laparoscopy in living donor renal transplantation. Transplant Proc 37: 4235-4240, 2005 (Pubitemid 43015998)
22. Kandaswamy R, Melancon JK, Dunn T, Tan M, Casingal V, Humar A, Payne WD, Gruessner RWG, Dunn DL, Najarian JS, Sutherland DER, Gillingham KJ, Matas AJ: A prospective randomized trial of steroid-free maintenance regimens in kidney transplant recipients. An interim analysis. Am J Transplant 5: 1529-1536, 2005 (Pubitemid 40839448)
23. Rostaing L, Cantarovich D, Mourad G, Budde K, Rigotti P, Mariat C, Margreiter R, Capdevilla L, Lang P, Vialtel P, Ortuno-Mirete J, Charpentier B, Legendre C, Sanchez-Plumed J, Oppenheimer F, Kessler M, Group CS, Rostaing L, Cantarovich D, Mourad G, Budde K, Rigotti P, Mariat C, Margreiter R, Capdevilla L, Lang P, Vialtel P, Ortuno-Mirete J, Charpentier B, Legendre C, Sanchez-Plumed J, Oppenheimer F, Kessler M: Corticosteroid-free immunosuppression with tacrolimus, mycophenolate mofetil, and daclizumab induction in renal transplantation. Transplantation 79: 807-814, 2005 (Pubitemid 40546200)
24. Alloway RR, Hanaway MJ, Trofe J, Boardman R, Rogers CC, Buell JF, Munda R, Alexander JW, Thomas MJ, Roy-Chaudhury P, Cardi M, Woodle ES: A prospective, pilot study of early corticosteroid cessation in high-immunologic-risk patients: The Cincinnati experience. Transplant Proc 37: 802-803, 2005 (Pubitemid 40590706)
25. Khwaja K, Asolati M, Harmon JV, Melancon JK, Dunn TB, Gillingham KJ, Kandaswamy R, Humar A, Gruessner RWG, Payne WD, Najarian JS, Dunn DL, Sutherland DER, Matas AJ: Rapid discontinuation of prednisone in higher-risk kidney transplant recipients. Transplantation 78: 1397-1399, 2004 (Pubitemid 39507982)
26. Birkeland SA: Steroid-free immunosuppression after kidney transplantation with antithymocyte globulin and cyclosporine and mycophenolate mofetil maintenance therapy. Transplantation 66: 1207-1210, 1998
27. Borrows R, Chan K, Loucaidou M, Lawrence C, Van Tromp J, Cairns T, Griffith M, Hakim N, McLean A, Palmer A, Papalois V, Taube D: Five years of steroid sparing in renal transplantation with tacrolimus and mycophenolate mofetil. Transplantation 81: 125-128, 2006 (Pubitemid 43122160)
28. Humar A, Gillingham K, Kandaswamy R, Payne W, Matas A: Steroid avoidance regimens: A comparison of outcomes with maintenance steroids versus continued steroid avoidance in recipients having an acute rejection episode. Am J Transplant 7: 1948-1953, 2007
29. Knight SR, Morris PJ: Steroid avoidance or withdrawal after renal transplantation increases the risk of acute rejection but decreases cardiovascular risk. A metaanalysis. Transplantation 89: 1-14, 2010
30. Luan FL, Steffick DE, Gadegbeku C, Norman SP, Wolfe R, Ojo AO: Graft and patient survival in kidney transplant recipients selected for steroid-free maintenance immunosuppression. Am J Transplant 9: 160-168, 2009
31. Etienne T, Goumaz C, Ruedin P, Jeannet M: Renal retransplantation in Switzerland: Poor HLA matching of first and subsequent allografts does not appear to affect overall graft survival. Transplant Int 5[Suppl 1]: S65-S66, 1992
32. Hornberger JC, Best JH, Garrison LP Jr: Cost-effectiveness of repeat medical procedures: Kidney transplantation as an example. Med Decision Making 17: 363-372, 1997 (Pubitemid 27444307)
33. Mouquet C, Benalia H, Chartier-Kastler E, Sylla C, Coriat P, Bitker MO, Richard F: [Renal retransplantation in adults. Comparative prognostic study]. Prog Urol 9: 239-243, 1999
34. Woodle ES, Alloway RR, Buell, JF, Alexander JW, Munda R, Roy-Chaudhury P, First MR, Cardi M, Trofe J: Multivariate analysis of risk factors for acute rejection in early corticosteroid cessation regimens under modern immunosuppression. Am J Transplant 5: 2740-2744, 2005
35. Yagmurdur MC, Emiroglu R, Ayvaz I, Sozen H, Karakayali H, Haberal M: The effect of graft nephrectomy on long-term graft function and survival in kidney retransplantation. Transplant Proc 37: 2957-2961, 2005 (Pubitemid 41435586)
36. Schold JD, Santos A, Rehman S, Magliocca J, Meier-Kriesche H-U: The success of continued steroid avoidance after kidney transplantation in the US. Am J Transplant 9: 2768-2776, 2009
37. ter Meulen CG, van Riemsdijk I, Hene RJ, Christiaans MH, Borm GF, van Gelder T, Hilbrands LB, Weimar W, Hoitsma AJ: Steroid-withdrawal at 3 days after renal transplantation with anti-IL-2 receptor alpha therapy: A prospective, randomized, multicenter study. Am J Transplant 4: 803-810, 2004
38. Fridell JA, Agarwal A, Powelson JA, Goggins WC, Milgrom M, Pescovitz MD, Tector AJ: Steroid withdrawal for pancreas after kidney transplantation in recipients on maintenance prednisone immunosuppression. Transplantation 82: 389-392, 2006 (Pubitemid 44223039)
39. Arnol M, de Mattos AM, Chung JS, Prather JC, Mittalhenkle A, Norman DJ: Late steroid withdrawal and cardiovascular events in kidney transplant recipients, Transplantation 86: 1844-1848, 2008
40. Rike AH, Mogilishetty G, Alloway RR, Succop P, Roy-Chaudhury P, Cardi M, Kaiser TE, Thomas M, Woodle ES: Cardiovascular risk, cardiovascular events, and metabolic syndrome in renal transplantation: Comparison of early steroid withdrawal and chronic steroids. Clin Transplant 22: 229-235, 2008 (Pubitemid 351420018)